Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
Latest Information Update: 16 Mar 2023
At a glance
- Drugs Follitropin delta (Primary)
- Indications Female infertility
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROFILE
- Sponsors Ferring Pharmaceuticals
- 14 Mar 2023 According to a Ferring Pharmaceuticals media release, Professor Christophe Blockeel, from Brussels IVF, the Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel and Vrije Universiteit Brussel is a principal investigator of this study.
- 14 Mar 2023 According to a Ferring Pharmaceuticals media release, data from this study were first published in the Frontiers of Endocrinology in December 2022.
- 14 Mar 2023 According to a Ferring Pharmaceuticals media release, data from this study are being presented at the 13th Congress of the Pacific Society for Reproductive Medicine (PSRM) 2023.